Zomato recovers 2% as bullish brokerages hike the target price

Shares of Zomato rose over 2 per cent on the NSE on Wednesday after it tanked two days post the company’s Q4 financial results, although analysts gave thumbs up to its performance. Analysts also expect its weightage in the MSCI EM Index likely to go up after today’s rejig by the global index major that will take effect from May 31.

Shares of Zomato rose over 2 per cent on the NSE on Wednesday after it tanked two days post the company’s Q4 financial results, although analysts gave thumbs up to its performance. Analysts also expect its weightage in the MSCI EM Index likely to go up after today’s rejig by the global index major that will take effect from May 31.

The food delivery aggregator platform had reported a consolidated net profit of ₹175 crore in the March quarter as against a net loss of ₹188 crore in the corresponding period in the previous fiscal.

Also read: Zomato hits 20-month high after delivering strong Q3The company had also disclosed that its subsidiary Zomato Payments Private Ltd has decided to voluntarily surrender the certificate of authorisation issued by RBI to operate as an online payment aggregator. 

Brokerages callMost brokerages, including Nuvama, Jefferies and Nomura , remained positive on the stock and retained their ‘buy’ ratings on Zomato. 

Domestic brokerage Kotak Securities maintained its ‘buy’ rating for the stock but cut the target price to ₹225 from ₹230. 

Emkay Global retained its ‘buy’ rating on the stock with a target price of ₹230 from the earlier ₹170. 

The analysts have increased FY25/FY26E EPS by 41-52 per cent (EBIT by 18-20 per cent) factoring in higher growth. margin assumptions for Blinkit and lower ETR. With better clarity on product-market fit and roadmap to profitability for Blinkit, they added, “we now value it on DCF, compared to 1x FY26E GOV earlier.” 

Analysts of JM Financial have increased GOV/Revenue estimates for Blinkit by 15-41 per cent over FY25/26, which has led to a change in SOTP-driven Mar’25 FV for the Zomato stock to ₹260 from ₹200 earlier. 

Maintaining ‘buy’ call, the brokerage quoted, “We expect Blinkit to double down on growth post break-even at Adj. EBITDA levels by 1QFY25, which should ensure exponential growth for the business in the near to medium term.” It is believed that Blinkit in the long term will command premium profit multiples to Zomato’s own food delivery business as it is relatively more sticky and a play on retail commerce (bigger TAM and longer growth runway). 

Also read: Zomato offers daily payout option for small restaurant playersGlobal brokerage Nomura said that the company’s food delivery business continues to grow steadily. 

UBS maintained its ‘buy’ call on the stock with a target price of ₹250.

Jefferies upped the target price to ₹230 from ₹200 and maintained the ‘buy’ call.  

CLSA, maintaining its ‘buy’ call, set the target price at ₹248. The brokerage highlighted the company’s strong guidance for Blinkit.

Meanwhile, Bernstein maintained its ‘outperform’ rating raising the target price to ₹230 from ₹200. 

The stock ended 2.14 per cent higher on Wednesday’s trade at ₹191.30 on the NSE.

It ended at ₹191.95 on the BSE, higher by 2.40 per cent.

Like (0)
Previous May 15, 2024 4:24 pm
Next May 15, 2024 10:58 pm

Related posts

  • Sebi bars Growpital, other related entities from securities markets; probe continues

    Markets regulator Sebi said that Farm Tech Silo LLP, also known as Growpital, other related entities and their directors will remain barred from securities markets till the outcome of a probe into collection of money through unauthorised investment schemes.

    US stock market April 29, 2024
  • Nordisk fell 1.1% in premarket as the U.S. Senate launches investigation into Novo Nordisk\’s GLP-1 drug pricing

    Gelonghui, April 25 | Nord Nordisk (NVO.US) U.S. stocks fell 1.1% before the market opened, to US$124.74. On the news, U.S. Senate Health, Education, Labor and Pensions Committee Chairman Bernie Sanders said on Wednesday that the committee is launching an investigation into Novo Nordisk\’s pricing. In a letter sent to Novo Nordisk\’s CEO on Wednesday, Sanders asked Novo Nordisk to provide \”internal communications about the U.S. pricing of the drug\” and explain why Ozempic and Wegovy have the same ingredient (semaglutide). ), Wegovy’s pricing is obviously more expensive. Sanders stressed that the price of GLP-1 drugs \”must come down\” so that consumers can afford them and the government doesn\’t go bankrupt by reimbursing them.

    US stock market April 25, 2024
  • Rongzhi Rixin (688768.SH): Net profit in 2023 will decrease by 45.98% year-on-year

    Gelonghui April 25 | Rongzhi Rixin (688768.SH) released its 2023 annual report. During the reporting period, the company achieved operating income of 498 million yuan, a year-on-year decrease of 8.96%; the net profit attributable to shareholders of the listed company was 62.6978 million yuan. , a year-on-year decrease of 45.98%; net profit attributable to shareholders of listed companies after excluding non-recurring gains and losses was 56.8342 million yuan, a year-on-year decrease of 45.12%; basic earnings per share was 0.77 yuan/share. The company plans to distribute a cash dividend of 1.15 yuan (tax included) to all shareholders for every 10 shares.

    US stock market April 25, 2024
  • Shanshi Network Technology: Loss of 75.4048 million yuan in the first quarter of 2024

    CSI Intelligent Financial Information Shanshi Network Technology (688030) disclosed its first quarter report for 2024 on April 26. In the first quarter of 2024, the company achieved total operating income of 151 million yuan, a year-on-year increase of 4.49%; net profit attributable to the parent company was a loss of 75.4048 million yuan, a loss of 87.4564 million yuan in the same period last year; a loss after deducting non-net profits was 75.7863 million yuan, a loss in the same period last year 91.9258 million yuan; the net cash flow generated from operating activities was -10.7085 million yuan, compared with -12.6281 million yuan in the same period last year; during the reporting period, Shanshi Network\’s basic earnings per share was -0.4184 yuan, and the weighted average return on net assets was -7.26%.

    US stock market April 25, 2024
  • NCC stock surges over 8% on strong Q4 results, brokerages bullish

    NCC stock surged over 8 per cent on the NSE on Thursday after the company’s Q4 financial results.

    US stock market May 16, 2024
  • China Resources Micro (688396.SH): Net profit in 2023 will decrease by 43.48% year-on-year

    Gelonghui April 25 | China Resources Micro (688396.SH) released its 2023 annual report. During the reporting period, the company achieved operating income of 9.901 billion yuan, a year-on-year decrease of 1.59%; net profit attributable to shareholders of listed companies was 1.479 billion yuan, a year-on-year decrease of 1.479 billion yuan. A decrease of 43.48%; net profit attributable to shareholders of listed companies after excluding non-recurring gains and losses was 1.127 billion yuan, a year-on-year decrease of 49.97%; basic earnings per share was 1.1206 yuan per share. The company plans to distribute a cash dividend of 1.118 yuan (tax included) to all shareholders for every 10 shares.

    US stock market April 25, 2024